Clinical Trial Update: Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan [NA]

View source ↗

Summary

A clinical trial update evaluating two flavours of Renalive LP, a high-energy, low-protein nutrition formula, for outpatients with chronic kidney disease stages…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Malnutrition

Drugs mentioned

• Renalive LP

Snippet

Sponsor: Fresenius Kabi Taiwan Ltd. | Conditions: CKD, Low Protein Dietary Intake | NA | Status: RECRUITING